Comprehensive medication management: Review and recommendations for quality measures

Author:

Haas Curtis E.1ORCID,Kliethermes Mary Ann2ORCID,Armistead Lori T.3ORCID,Beavers Craig4ORCID,Schumacher Christie5ORCID,Smith Lisa6,Armitstead John A.7,Emmons Roshni P.8ORCID,Darakjian Lucy9ORCID,Edwards Krystal L.10ORCID,Barr Michael1112ORCID,

Affiliation:

1. Department of Pharmacy University of Rochester Medical Center Rochester New York USA

2. Office of Pharmacy Practice American Society of Health‐Systems Pharmacists Bethesda Maryland USA

3. Center for Medication Optimization, Eshelman School of Pharmacy University of North Carolina Chapel Hill North Carolina USA

4. Pharmacy Practice & Science Department, College of Pharmacy University of Kentucky Lexington Kentucky USA

5. Department of Pharmacy Practice, College of Pharmacy Midwestern University Downers Grove Illinois USA

6. Department of Psychiatry Rocky Mountain Regional VA Medical Center Aurora Colorado USA

7. Department of Pharmacy Lee Health Fort Myers Florida USA

8. Department of Pharmacy Practice Jefferson College of Pharmacy Philadelphia Pennsylvania USA

9. Scientific Precision Pharmacotherapy Research & Development Institute Tabula Rasa HealthCare Orlando Florida USA

10. Department of Pharmacy Practice Texas Tech Jerry H. Hodge School of Pharmacy—DFW Campus Dallas Texas USA

11. GTMRx Institute Vienna Virginia USA

12. MEDIS, National Harbor Oxon Hill Maryland USA

Abstract

AbstractComprehensive medication management (CMM) provided by a clinical pharmacist can improve the quality of care and reduce health care costs through the optimization of medication use and a significant reduction in medication‐related problems. As demonstrated by multiple research studies and detailed in published use cases, CMM should be an essential practice for improving population health. This narrative review discusses the limitations of the current evidence and recommends structure, process, and outcome measures to ensure that the key elements of CMM that drive the observed benefits are implemented with fidelity to address the goals of the quadruple aim. The proposed outcome measures are further sub‐classified into economic, clinical, and humanistic categories. Several medication‐related measures are recommended to help define the importance and value of CMM as a key component of population health management.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacy

Reference60 articles.

1. TikkanenR AbramsM U.S. Health Care from a global perspective 2019: higher spending worse outcomes?;2019https://www.commonwealthfund.org/publications/issue-briefs/2020/jan/us-health-care-global-perspective-2019. Accessed 20 Dec 2020.

2. Cost of Prescription Drug–Related Morbidity and Mortality

3. US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3